Founded in 2001, Tricol is dedicated to significantly advancing the standard of care in hemostatic and wound care management. The company's HemCon product line, which originated on the battlefield, has expanded to address market needs in Trauma Management, Procedural Care, and Consumer Self-Care. Tricol Biomedical operates at the forefront of bleeding control and wound care technology, emphasizing quality and innovation. Currently headquartered in the United States, the company's latest investment details, including investors and date, are currently unavailable.
General Information
Get notified when Tricol Biomedical, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Tricol Biomedical, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Tricol Biomedical, Inc.
Taxonomy: hemostasis, wound care, hemostatic, trauma management, procedural care, consumer care, bleeding control, innovation, life-saving technology
No funding data available for Tricol Biomedical, Inc. yet.
Get notified when Tricol Biomedical, Inc. raises fundingTricol Biomedical, Inc. Alternatives & Competitors
Healing is in Our Blood
West Coast Wound and Skin Care is committed to providing high-quality care to the individuals we ser...
Revolutionizing wound care through technology
FAQ About Tricol Biomedical, Inc.
Don't just browse. Track.
Signal Tracker monitors Tricol Biomedical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.